Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice

J Immunol. 1991 Oct 1;147(7):2284-9.

Abstract

Adult mice injected with Moloney murine leukemia virus (M-MuLV) 1 day after a short term treatment with anti-CD4 mAb developed T cell lymphomas, or sarcomas when rechallenged with Moloney murine sarcoma virus (M-MSV). Neoplastic development was correlated with virus spread, as thymic and peripheral T and B lymphocytes promptly expressed M-MuLV-induced Ag after virus introduction; no virus-specific CTL generation was detected in MLTC. This failure, which was selective for M-MuLV-induced Ag, persisted throughout the life span of the mice, and was not sustained by suppressor cell activity. The frequencies of splenic virus-specific CTL precursor varied in relation to time after virus injection; in the first postinjection month, frequencies were similar to those in nonimmune control mice, while at 4 mo post-virus exposure, they showed a striking reduction. These findings indicate that a transient functional impairment of CD4+ cells at the time of retrovirus injection provided the appropriate milieu for tolerance induction in both the peripheral mature and intrathymic T cell compartments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antigens, Viral / analysis
  • CD4 Antigens / immunology*
  • Immune Tolerance*
  • Leukemia, Experimental / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Moloney murine leukemia virus / immunology*
  • Moloney murine sarcoma virus / immunology
  • Rats
  • Sarcoma, Experimental / immunology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes, Cytotoxic / physiology
  • T-Lymphocytes, Regulatory / physiology

Substances

  • Antibodies, Monoclonal
  • Antigens, Viral
  • CD4 Antigens